EndocrinologyTRANSNCT07163832
Retrospective Study of the Cohort of Transgender Patients Who Began Medical Support Before the Age of 18
An observational study of Endocrinology, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
Gender incongruence is characterized by a marked and persistent incongruity between the gender with which a person identifies and their assigned sex. Behaviors and preferences that vary by sex do not, in and of themselves, justify the assignment of diagnoses in this group. Read more about this study
- Who is it for?
- Ages 8 to 17 years
- Conditions the study is for
- Endocrinology
- How many people
- 115 participants
- Where
- 1 siteFrance
- Study dates
- 15 May 2025to 15 May 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 8 to 17 years
- All sexes
- No healthy volunteers
- Child
Study population: Minor patient (≥18 years old) who has been consulted for the first time for transgender issues at the Strasbourg University Hospital in child psychiatry and/or pediatric endocrinology (in at least one of the two departments)
Who may be able to join
- Minor patient (≥18 years old)
- First-time patient for transgender issues at the Strasbourg University Hospital in child psychiatry and/or pediatric endocrinology (in at least one of the two departments)
- Patient (and/or their legal representative) who has not expressed opposition to the reuse of their data for scientific research purposes.
Who cannot join
- Patient (and/or their representative) who has expressed opposition to the reuse of their data for scientific research purposes.
- Patient aged over 18 at the first consultation
- Patient with insufficient data
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service de pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, 67091
François BREZIN, MD, 03.88.12.77.34, francois.brezin@chru-strasbourg.fr
François BREZIN, MD
About this study
Official title: Retrospective Single-center Study of the Cohort of Transgender Patients Who Began Medical Support Before the Age of 18 at the Strasbourg University Hospital
Gender incongruence is characterized by a marked and persistent incongruity between the gender with which a person identifies and their assigned sex. Behaviors and preferences that vary by sex do not, in and of themselves, justify the assignment of diagnoses in this group.
- Conditions
- Endocrinology
- Keywords
- Pediatric endocrinology, Child Psychiatry
What is being measured
The primary outcome is the main question the study is designed to answer.
Retrospective descriptive study of the population of transgender minors receiving medical support at the Strasbourg University Hospital
Measured: Up to 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Sep 2025
- Study start15 May 2025
- Primary completionMay 2026 (estimated)
- Study completion15 May 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EndocrinologyStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 115 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07163832
- Sponsor's protocol ID
- 9688
- Acronym
- TRANS
- Status last verified
- Sep 2025
- First submitted
- 1 Sep 2025
- Last updated
- 9 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Retrospective Single-center Study of the Cohort of Transgender Patients Who Began Medical Support Before the Age of 18 at the Strasbourg University Hospital
- ClinicalTrials.gov ID
- NCT07163832
- Acronym / sponsor ID
- TRANS / 9688
- Conditions
- Endocrinology
- Keywords
- Pediatric endocrinology, Child Psychiatry
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 115 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 15 May 2025 (actual)
- Primary completion
- May 2026 (estimated)
- Study completion
- 15 May 2026 (estimated)
- First posted
- 9 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Gender incongruence is characterized by a marked and persistent incongruity between the gender with which a person identifies and their assigned sex. Behaviors and preferences that vary by sex do not, in and of themselves, justify the assignment of diagnoses in this group.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 8 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Minor patient (≥18 years old) who has been consulted for the first time for transgender issues at the Strasbourg University Hospital in child psychiatry and/or pediatric endocrinology (in at least one of the two departments)
Key inclusion criteria (3 listed)
- Minor patient (≥18 years old)
- First-time patient for transgender issues at the Strasbourg University Hospital in child psychiatry and/or pediatric endocrinology (in at least one of the two departments)
- Patient (and/or their legal representative) who has not expressed opposition to the reuse of their data for scientific research purposes.
Key exclusion criteria (3 listed)
- Patient (and/or their representative) who has expressed opposition to the reuse of their data for scientific research purposes.
- Patient aged over 18 at the first consultation
- Patient with insufficient data
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Retrospective descriptive study of the population of transgender minors receiving medical support at the Strasbourg University Hospital
Time frame: Up to 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Sep 2025.
Related trials for Endocrinology
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Endocrinology, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 9 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact François BREZIN, MD (03.88.12.77.34, francois.brezin@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Retrospective descriptive study of the population of transgender minors receiving medical support at the Strasbourg University Hospital (time frame: Up to 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2025.